RE:RE:RE:NewsHad you read the Clinicaltrials.gov site properly you would have understood the protocol clearly states,
"if intense visualization is observed at 10 minutes..." Now please refer to the press release issued by the company in July of 2018 stating it was recognized at 15 minutes.
https://imaginmedical.com/wp-content/uploads/2018/07/Press-Release-7-17-17-Research-Study-Progress.pdf This is significant since the drug typically takes 60 minutes to express.
Furthermore, a trial must remain open for 1 year which had you actually read the document you would have seen the trial date started
Nov 2017 and ended on
July 2018. Results first posted for the 2017 trial were on August 19, 2019. Last updated on August 2019. You cannot post results until the official end of a trial. There was no recent trial as you suggest and you look like a fool trying to spread false and misleading statements.
In short the 2017 trial allowed the company to see Dr. Messing's original prototype was workable and as a result, today the company has best-in-breed technology on the cusp of commercialization.
No recent trials. The 2017 trial he is referencing was the thesis for moving forward.
End of subject.